Pacific Biosciences of California, Inc. (PACB) is the developer of the PacBio RS II, a next-generation sequencing system expanding the field of science. The company develops, manufactures, and markets the high-end sequencing platform. This places the company in the same industry as more recognizable names such as Illumina (ILMN) and Thermo Fisher (formerly Life Technologies Corporation). The system utilizes Single Molecule, Real-Time DNA sequencing technology which provides the highest consensus accuracy and longest read lengths in the gene-sequencing industry.
The company remains a lesser known name despite its significant advances in technology. Initially plagued by high error run rates, the original PacBio system was largely dismissed by the industry early on. Yet critical...
Only subscribers can access this article, which is part of the PRO research library covering 3,609 different stocks.
Growing numbers of fund managers and other investment professionals subscribe to Seeking Alpha PRO for equity research that is unavailable elsewhere, so they can: